Who invested in Design Therapeutics?
Design Therapeutics's investors include RA Capital Management, Wellington Management, BlackRock, Cormorant Asset Management and Vivo Capital.
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$125Mraised across 1 round since 2021, from 1 source
Source recordedSEC filing: $125M sold, first sale Jan 2021
Design Therapeutics's investors include RA Capital Management, Wellington Management, BlackRock, Cormorant Asset Management and Vivo Capital.
Design Therapeutics has raised $125M across 1 round since 2021.
Design Therapeutics's most recent round was a Series B of $125M in Jan 2021.
Its most recent round, $125M in Jan 2021, is also its largest on record.
Design Therapeutics's first round on record, in Jan 2021, was backed by RA Capital Management, Wellington Management and BlackRock and 2 others.
Design Therapeutics's latest named round is a Series B, in Jan 2021.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.